142 related articles for article (PubMed ID: 16234512)
1. Utilization of diagnostic studies in the pretreatment evaluation of invasive cervical cancer in the United States: results of intergroup protocol ACRIN 6651/GOG 183.
Amendola MA; Hricak H; Mitchell DG; Snyder B; Chi DS; Long HJ; Fiorica JV; Gatsonis C
J Clin Oncol; 2005 Oct; 23(30):7454-9. PubMed ID: 16234512
[TBL] [Abstract][Full Text] [Related]
2. Patterns of pretreatment diagnostic assessment and staging for patients with cervical cancer (1999-2001): patterns of care study in Japan.
Toita T; Kodaira T; Uno T; Shinoda A; Akino Y; Mitsumori M; Teshima T
Jpn J Clin Oncol; 2008 Jan; 38(1):26-30. PubMed ID: 18202031
[TBL] [Abstract][Full Text] [Related]
3. Role of imaging in pretreatment evaluation of early invasive cervical cancer: results of the intergroup study American College of Radiology Imaging Network 6651-Gynecologic Oncology Group 183.
Hricak H; Gatsonis C; Chi DS; Amendola MA; Brandt K; Schwartz LH; Koelliker S; Siegelman ES; Brown JJ; McGhee RB; Iyer R; Vitellas KM; Snyder B; Long HJ; Fiorica JV; Mitchell DG; ;
J Clin Oncol; 2005 Dec; 23(36):9329-37. PubMed ID: 16361632
[TBL] [Abstract][Full Text] [Related]
4. Changing trend in the patterns of pretreatment diagnostic assessment for patients with cervical cancer in Japan.
Tomita N; Toita T; Kodaira T; Shinoda A; Uno T; Numasaki H; Teshima T; Mitsumori M
Gynecol Oncol; 2011 Dec; 123(3):577-80. PubMed ID: 21945554
[TBL] [Abstract][Full Text] [Related]
5. Diagnostic assessments in patients with invasive cancer of the cervix: a national patterns of care study of the American College of Surgeons.
Russell AH; Shingleton HM; Jones WB; Fremgen A; Winchester DP; Clive R; Chmiel JS
Gynecol Oncol; 1996 Nov; 63(2):159-65. PubMed ID: 8910621
[TBL] [Abstract][Full Text] [Related]
6. ACR Appropriateness Criteria® pretreatment planning of invasive cancer of the cervix.
Siegel CL; Andreotti RF; Cardenes HR; Brown DL; Gaffney DK; Horowitz NS; Javitt MC; Lee SI; Mitchell DG; Moore DH; Rao GG; Royal HD; Small W; Varia MA; Yashar CM;
J Am Coll Radiol; 2012 Jun; 9(6):395-402. PubMed ID: 22632665
[TBL] [Abstract][Full Text] [Related]
7. Early invasive cervical cancer: tumor delineation by magnetic resonance imaging, computed tomography, and clinical examination, verified by pathologic results, in the ACRIN 6651/GOG 183 Intergroup Study.
Mitchell DG; Snyder B; Coakley F; Reinhold C; Thomas G; Amendola M; Schwartz LH; Woodward P; Pannu H; Hricak H
J Clin Oncol; 2006 Dec; 24(36):5687-94. PubMed ID: 17179104
[TBL] [Abstract][Full Text] [Related]
8. Primary uterine cervical cancer: correlation of preoperative magnetic resonance imaging and clinical staging (FIGO) with histopathology findings.
Kraljević Z; Visković K; Ledinsky M; Zadravec D; Grbavac I; Bilandzija M; Soljacić-Vranes H; Kuna K; Klasnić K; Krolo I
Coll Antropol; 2013 Jun; 37(2):561-8. PubMed ID: 23941005
[TBL] [Abstract][Full Text] [Related]
9. Stage II endometrioid adenocarcinoma of the endometrium: clinical implications of cervical stromal invasion.
Orezzoli JP; Sioletic S; Olawaiye A; Oliva E; del Carmen MG
Gynecol Oncol; 2009 Jun; 113(3):316-23. PubMed ID: 19345400
[TBL] [Abstract][Full Text] [Related]
10. Treatment of ("bulky") stage IB cervical cancer with or without neoadjuvant vincristine and cisplatin prior to radical hysterectomy and pelvic/para-aortic lymphadenectomy: a phase III trial of the gynecologic oncology group.
Eddy GL; Bundy BN; Creasman WT; Spirtos NM; Mannel RS; Hannigan E; O'Connor D
Gynecol Oncol; 2007 Aug; 106(2):362-9. PubMed ID: 17493669
[TBL] [Abstract][Full Text] [Related]
11. Clinical staging and histopathological findings after radical hysterectomy in FIGO stage IIB cervical cancer.
Mandic A; Novakovic P; Mihajlovic O; Stojiljkovic B; Rajovic J; Davidovic M
J BUON; 2008; 13(1):51-4. PubMed ID: 18404786
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of carcinoma cervix using magnetic resonance imaging: correlation with clinical FIGO staging and impact on management.
Dhoot NM; Kumar V; Shinagare A; Kataki AC; Barmon D; Bhuyan U
J Med Imaging Radiat Oncol; 2012 Feb; 56(1):58-65. PubMed ID: 22339747
[TBL] [Abstract][Full Text] [Related]
13. The treatment of early stage cervical cancer: an assessment of pre-operative factors.
Buekers TE; Kao MS; Phillips NJ; Xynos FP
Gynecol Oncol; 2007 Mar; 104(3):665-9. PubMed ID: 17112568
[TBL] [Abstract][Full Text] [Related]
14. Gynecologic examination and cervical biopsies after (chemo) radiation for cervical cancer to identify patients eligible for salvage surgery.
Nijhuis ER; van der Zee AG; in 't Hout BA; Boomgaard JJ; de Hullu JA; Pras E; Hollema H; Aalders JG; Nijman HW; Willemse PH; Mourits MJ
Int J Radiat Oncol Biol Phys; 2006 Nov; 66(3):699-705. PubMed ID: 16904839
[TBL] [Abstract][Full Text] [Related]
15. Assessing disease extent in women with bulky or clinically evident metastatic cervical cancer: yield of pretreatment studies.
Massad LS; Calvello C; Gilkey SH; Abu-Rustum NR
Gynecol Oncol; 2000 Mar; 76(3):383-7. PubMed ID: 10684715
[TBL] [Abstract][Full Text] [Related]
16. A multi-institutional experience with robotic-assisted radical hysterectomy for early stage cervical cancer.
Lowe MP; Chamberlain DH; Kamelle SA; Johnson PR; Tillmanns TD
Gynecol Oncol; 2009 May; 113(2):191-4. PubMed ID: 19249082
[TBL] [Abstract][Full Text] [Related]
17. Can MRI rule out bladder and rectal invasion in cervical cancer to help select patients for limited EUA?
Rockall AG; Ghosh S; Alexander-Sefre F; Babar S; Younis MT; Naz S; Jacobs IJ; Reznek RH
Gynecol Oncol; 2006 May; 101(2):244-9. PubMed ID: 16310245
[TBL] [Abstract][Full Text] [Related]
18. Surgery in recurrent ovarian cancer: the Arbeitsgemeinschaft Gynaekologische Onkologie (AGO) DESKTOP OVAR trial.
Harter P; du Bois A; Hahmann M; Hasenburg A; Burges A; Loibl S; Gropp M; Huober J; Fink D; Schröder W; Muenstedt K; Schmalfeldt B; Emons G; Pfisterer J; Wollschlaeger K; Meerpohl HG; Breitbach GP; Tanner B; Sehouli J; ;
Ann Surg Oncol; 2006 Dec; 13(12):1702-10. PubMed ID: 17009163
[TBL] [Abstract][Full Text] [Related]
19. Invasive cervical carcinoma: role of MR imaging in pretreatment work-up--cost minimization and diagnostic efficacy analysis.
Hricak H; Powell CB; Yu KK; Washington E; Subak LL; Stern JL; Cisternas MG; Arenson RL
Radiology; 1996 Feb; 198(2):403-9. PubMed ID: 8596840
[TBL] [Abstract][Full Text] [Related]
20. Participation of the general gynecologist in surgical staging of endometrial cancer: analysis of cost and perioperative outcomes.
Hoekstra A; Singh DK; Garb M; Arekapudi S; Rademaker A; Lurain JR
Gynecol Oncol; 2006 Dec; 103(3):897-901. PubMed ID: 16814370
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
